Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Eureka Genomics Lands a NIFA Award for $100,000

Published: Thursday, June 28, 2012
Last Updated: Thursday, June 28, 2012
Bookmark and Share
Development of bovine parentage genotyping by highly multiplex next generation sequencing.

The National Institute of Food and Agriculture (NIFA), USDA issued a $100,000 award for the development of Bovine Parentage Genotyping by Highly Multiplex Next Generation Sequencing.

This project is related to a Cooperative Research and Development Agreement (CRADA) between Eureka Genomics and the Agricultural Research Service, USDA to develop a low cost, low-density marker assay (LDMA) focused on the bovine industry.

The core technology for low cost high-throughput genotyping will have applications across animal, plant and clinical markets.

"The collaboration has resulted in a very cost-effective, high-throughput approach to single nucleotide polymorphism (SNP) genotyping, which is currently available for bovine parentage testing as well as for custom applications. Continuing development efforts are focused on increasing the number of SNPs that can be included in an assay, on further reducing the costs of adding SNP to assays, and on expanding the approach to include additional types of polymorphisms," said Mark Thallman, Ph.D. Research Geneticist and co-inventor of the technology, at the U.S. Meat Animal Research Center.

"The success of and knowledge created during the collaboration between Eureka Genomics and the USDA on LDMA for high-throughput genotyping is being leveraged into an ongoing collaboration between Eureka Genomics and the USDA that has expanded to include many diverse areas including 16S characterization and improved sample handling for next generation sequencing. Eureka Genomics is very pleased to continue to work with the U.S. Meat Animal Research Center to improve the applications of high throughput sequence data in the agricultural setting," said Heather Koshinsky, PhD., CSO, Eureka Genomics.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!